Oncobesity News Posts

New Year, New Strategy: Navigating Weight Loss ETFs
With the start of 2026, the annual focus on weight loss resolutions presents a timely opportunity for financial advisors to discuss the investment potential of

Dr. Drew Says GLP-1 Drugs May Have Helped Nick Reiner, But It’s Delicate Balance
Nick Reiner’s weight gain set him on a murderous path, but it didn’t have to be that way … just ask Dr. Drew. The good

#JPM26: Novo Nordisk CEO says pharma can learn from the GLP-1 compounding boom
Pharma has much to learn from the surprising boom of telehealth sales of obesity drugs, Novo Nordisk’s CEO Mike Doustdar said at the Endpoints at

Pfizer CEO Bourla Says Company Looking For ‘Superior’ Results from Weight-Loss Drugs
Pfizer CEO Albert Bourla told Bloomberg’s Katie Greifeld Pfizer is looking for ‘superior results’ while developing and testing further GLP-1 weight loss medications in a

Semaglutide Attenuates Neuroinflammation in Mice
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown promise in preclinical models of neurodegeneration, with emerging evidence suggesting these effects may be driven by modulation

‘Desperate Housewives’ Star Reveals 2-Year Mounjaro Journey
Photo Illustration by Thomas Levinson/The Daily Beast/Getty Actress Vanessa Williams, 62, revealed she has been on GLP-1 drugs for the last two years. “It’s a

Monday assorted links
1. The (strong) case for beans (WSJ). 2. Education is correlated with liberal and pro-market views in most countries. 3. Puffin photos. 4. Do GLP-1

New comment by Aurornis in “Ozempic reduced grocery spending by an average of 5.3% in the US”
> In my friend circle in Germany I don’t even know one single person on this stuff. Most people don’t announce when they’re taking a

The Weekly Whiskey 01/12/2025
Full version can be found on Dread: https://dreadytofatroptsdj6io7l3xptbet6onoyno2yv7jicoxknyazubrad.onion/post/a9fa8a5deb3a54b33fb7 Tor browser is required to access any .onion links. 🦸 ✅ SUPERLIST MARKETS ✅ – /d/DarkMatterMarket –

Tom Brady joins telehealth startup to help sell GLP-1s
Of all the television personalities on GLP-1s like Ozempic, Tom Brady doesn’t appear to be one of them. You don’t play in the NFL into

ASCO GI: GLP-1 Receptor Agonist Use Linked to Reduced CRC Incidence
MONDAY, Jan. 12, 2026 — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for colorectal cancer (CRC) incidence compared with

This GLP-1 mistake can make you gain weight 4 times faster than stopping diet and exercise
While GLP-1s boast impressive weight loss results, making one mistake could result in the pounds coming right back on, according to new research.

诺和诺德首席执行官指出美国有150万复合GLP-1药物使用者
Novo Nordisk CEO flags 1.5 million US users of compounded GLP-1 drugs (www.reuters.com) 01:37

Ozempic made rapid weight loss easier. But here’s when keeping body fat is healthier, according to doctors
Back in the 2010s, celebrating bodies of all sizes was the rage. People magazine featured plus-size model Tess Holliday on the cover after her 2013

Jim Cramer Highlights Procter & Gamble’s Recent Rally
The Procter & Gamble Company (NYSE:PG) is one of the stocks from different market sectors that Jim Cramer commented on. Cramer mentioned the stock while

Tom Brady becomes ‘chief wellness officer’ at weight-loss shot company
The startup helps companies cover the high cost of GLP-1 drugs for employees

Novo Nordisk CEO Flags 1.5 Million US Users of Compounded GLP-1 Drugs
Jan 12 (Reuters) – Novo Nordisk CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using compounded

Full-service restaurants ‘haven’t really been impacted’ by GLP-1 usage, according to Darden CEO Rick Cardenas
The chief executive and CFO Raj Vennam talked long-term growth plans at the ICR Conference

Novo Nordisk CEO flags 1.5 million US users of compounded GLP-1 drugs – Reuters
Novo Nordisk CEO flags 1.5 million US users of compounded GLP-1 drugs Reuters

Ocado launches ‘small steak’ in new aisle for people on weight loss jabs
It follows retailers including Marks & Spencer, Waitrose and Greggs in advertising new ranges catering for those taking GLP-1 drugs.

IJMS, Vol. 27, Pages 759: A Systematic Review on GLP-1 Receptor Agonists in Reproductive Health: Integrating IVF Data, Ovarian Physiology and Molecular Mechanisms
IJMS, Vol. 27, Pages 759: A Systematic Review on GLP-1 Receptor Agonists in Reproductive Health: Integrating IVF Data, Ovarian Physiology and Molecular Mechanisms International Journal

The hidden health risk of taking weight loss drugs – and what to do about it
A recent review found that many people taking GLP-1 drugs receive little or no meaningful nutrition advice

Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity
Publication Highlights Impressive Weight Loss of Up to 14.7% from Baseline After 13 Weeks of Treatment; No Plateau Observed VK2735 Currently Being Evaluated in VANQUISH

What are GLP-3s? Meet the new generation of weight-loss drugs with three key ingredients
GLP-1 has become a popular buzzword in the weight-loss community — but now some are touting “GLP-3s,” claiming they are taking obesity medications to the

Amazon Pharmacy offers Wegovy weight-loss pill
Amazon Pharmacy began offering Novo Nordisk’s Wegovy weight-loss pill, a move likely to intensify the drug’s impact on waistlines, grocery bills, and the food industry

Suvannavejh: The obesity space has become a major focus for investors
Graig Suvannavejh, Biotech and Biopharma Analyst at Mizuho Securities, says Oral GLP-1 obesity drugs and looming patent cliffs will drive big pharma into biotech M&A,

Consumer Trends 2026: 10 Key Facts Every CMO Should Consider
FOTOARTE: MERCA2.0 What are the consumer trends for 2026? The consumer is no longer the same as just two years ago. More demanding, more hybrid,

How to Suppress Your Appetite and Naturally Boost GLP-1
Can eating more fiber result in eating fewer calories by suppressing our appetite? For more on fiber, check out: • Is Fiber an Effective Anti-Inflammatory?

Causes And Implications Of Discontinuing GLP-1 Weight Loss Drugs
Discontinuing obesity medicines means the weight comes back and people lose the cardiovascular and metabolic benefits conferred by the drugs.

Crypto Founder Behind ‘Ponzi’ Metaverse Linked to Illegal Drug Bust
A Guardian investigation has uncovered evidence linking Northampton-based crypto entrepreneur Fasial Tariq to what authorities described as the world’s largest illegal weight-loss drug operation. The

Major supermarket launches small 100g ‘steak’ in new ‘weight management’ aisle
Ocado’s ‘weight management’ aisle includes smaller portions and high-protein meals designed for customers on GLP-1 medications like Wegovy

Humana’s CenterWell Pharmacy Launches Employer Venture Using Lilly’s GLP-1 Drugs
Humana’s CenterWell pharmacy will dispense GLP-1 weight loss drugs made by Eli Lilly as part of a new program for employers to help their workers

Best Posts Last Week: Five Free Night Bonus, 4% Brokerage Bonus & More
Chase has brought back the popular Marriott Bonvoy Boundless offer of five free night certificates (up to 50,000 points). Wells Fargo has increased the sign

Weight loss drugs make it harder to get the nutrients you need—here’s what to do about it
Weight-loss drugs such as Ozempic, Wegovy and Mounjaro work primarily by reducing hunger. They mimic a hormone the body already produces called glucagon-like peptide-1 (GLP-1),

Supplement Tied to Stroke Risk; Cheese Recall Is Most Serious; GLP-1 Pioneer Dies
(MedPage Today) — Note that some links may require registration or subscription. Silintan capsules, a dietary supplement marketed for joint and body aches, have been

Lexaria’s DehydraTECH shows reduced side effects in GLP-1 drugs

10 Stars Whose Dramatic Transformations Stunned Fans At The 2026 Golden Globes
The 2026 Golden Globes dazzled Hollywood at the Beverly Hilton Hotel in California on January 11, celebrating some of the biggest names in film and

Health Canada approves 1st GLP-1 daily pill. Here’s who can take it
The once-a-day semaglutide pill is approved for reducing the risk of heart disease and Type 2 diabetes, the company said in a statement Monday.

What is ‘natural Ozempic’ – and how good is the science?
As slimming jabs explode in popularity, interest is growing in a potential alternative, in the form of a weight-loss supplement sometimes called “natural Ozempic”. It

Rising Public Interest in Weight Loss Medications and Growing Awareness of Their Aesthetic Sequelae: An Infodemiologic Google Trends Analysis and Clinical Diagnostic Patterning
ABSTRACT Background Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have gained rapid popularity for both medical and consumer-directed weight loss. This growth has been accompanied by